当前位置: X-MOL 学术J. Correct. Health Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Compulsory Psychotropic Medication in the California State Prison System.
Journal of Correctional Health Care ( IF 1.2 ) Pub Date : 2023-05-23 , DOI: 10.1089/jchc.22.02.0014
Bill A Davies 1 , George H Loeffler 2
Affiliation  

In Washington v. Harper, the U.S. Supreme Court established that an administrative review conducted by prison staff was the minimum constitutionally appropriate due process for the administration of compulsory nonemergent antipsychotic medication. California's current process, Penal Code section 2602 (PC2602), uses a judicial review allowing for either emergent (medication beginning with application) or nonemergent routes. This article describes the history culminating with PC2602, beginning with the notion of civil death enacted in 1850, followed by the 1986 Keyhea injunction. Framed by problems that emerged, PC2602 was enacted in 2011, which is described from both legal-administrative and clinical perspectives.

中文翻译:

加利福尼亚州监狱系统中的强制精神药物。

在华盛顿诉哈珀一案中,美国最高法院认定,监狱工作人员进行的行政审查是强制非紧急抗精神病药物管理的最低宪法适当程序。加州目前的程序,《刑法典》第 2602 条 (PC2602),采用司法审查,允许紧急(从应用开始的药物治疗)或非紧急途径。本文描述了 PC2602 的历史,从 1850 年颁布的民事死亡概念开始,随后是 1986 年的 Keyhea 禁令。针对出现的问题,PC2602于2011年颁布,从法律、行政和临床两个角度进行了描述。
更新日期:2023-05-23
down
wechat
bug